Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation
暂无分享,去创建一个
F. J. Ahmed | Afzal Hussain | A. Hussain | A. Samad | M. N. Ahsan | S. K. Singh | Abdus Samad | A. Faruk | M. W. Haque | A. Faruk | F. Ahmed | M. Haque | Mohd Neyaz Ahsan | Sandeep Kumar Singh | Abdul Faruk | Farhan Jalees Ahmed
[1] K. Creek,et al. Evaluation of transdermal penetration enhancers using a novel skin alternative. , 1997, Journal of pharmaceutical sciences.
[2] P A Bowser,et al. Isolation, barrier properties and lipid analysis of stratum compactum, a discrete region of the stratum corneum , 1985, The British journal of dermatology.
[3] A. Hussain,et al. Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B , 2015, Drug development and industrial pharmacy.
[4] P. Elias,et al. The Stratum Corneum Revisited , 1996, The Journal of dermatology.
[5] Puneet Utreja,et al. Localized delivery of paclitaxel using elastic liposomes: Formulation development and evaluation , 2011, Drug delivery.
[6] Huibi Xu,et al. Podophyllotoxin-loaded solid lipid nanoparticles for epidermal targeting. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[7] L. H. Reddy,et al. Enhancer aided in vitro permeation of atenolol and prazosin hydrochloride through mice skin. , 2001, Indian journal of experimental biology.
[8] Natas˘a S˘kalko,et al. Liposomes with Metronidazole for Topical Use: The Choice of Preparation Method and Vehicle , 1998 .
[9] O Sonneville-Aubrun,et al. Nanoemulsions: a new vehicle for skincare products. , 2004, Advances in colloid and interface science.
[10] J. Irache,et al. Poly(ε-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity , 1997 .
[11] Thalita Pedroni Formariz,et al. Microemulsoes e fases liquidas cristalinas como sistemas de liberacao de farmacos , 2005 .
[12] N. Jain,et al. Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. , 2013, Life sciences.
[13] Kamalinder K. Singh,et al. Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A , 2008, AAPS PharmSciTech.
[14] M. C. Popescu,et al. Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity. , 1992, Biochimica et biophysica acta.
[15] L. Chan,et al. Characterization of spreadability of nonaqueous ethylcellulose gel matrices using dynamic contact angle. , 2008, Journal of pharmaceutical sciences.
[16] Manohar Balaraman,et al. In vitro studies on liposomal amphotericin B obtained by supercritical carbon dioxide-mediated process. , 2007, Nanomedicine : nanotechnology, biology, and medicine.
[17] T. Tadros,et al. Formation and stability of nano-emulsions. , 2004, Advances in colloid and interface science.
[18] John H. Draize,et al. METHODS FOR THE STUDY OF IRRITATION AND TOXICITY OF SUBSTANCES APPLIED TOPICALLY TO THE SKIN AND MUCOUS MEMBRANES , 1944 .
[19] C. Santilli,et al. Doxorubicin biocompatible O/W microemulsion stabilized by mixed surfactant containing soya phosphatidylcholine. , 2006, Colloids and surfaces. B, Biointerfaces.
[20] V. Carelli,et al. Effect of vehicles on yohimbine permeation across excised hairless mouse skin. , 1998, Pharmaceutica acta Helvetiae.
[21] E. W. Kellogg,et al. Liposome oxidation and erythrocyte lysis by enzymically generated superoxide and hydrogen peroxide. , 1977, The Journal of biological chemistry.
[22] A. Dinda,et al. Effect of the composition of lecithin/n-propanol/isopropyl myristate/water microemulsions on barrier properties of mice skin for transdermal permeation of tetracaine hydrochloride: in vitro. , 2006, Colloids and surfaces. B, Biointerfaces.
[23] B. Guglielmo,et al. Lipid formulations of amphotericin B: clinical efficacy and toxicities. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] Hong Yuan,et al. Preparation and characteristics of monostearin nanostructured lipid carriers. , 2006, International journal of pharmaceutics.
[25] M. Basri,et al. Formation and stability of new palm-based nanoemulsions , 2008 .
[26] Tg. Repeated Dose Dermal Toxicity: 21/28-Day Study (OECD TG 410) , 2018, OECD Series on Testing and Assessment.
[27] M. Kleinberg. What is the current and future status of conventional amphotericin B? , 2006, International journal of antimicrobial agents.
[28] H. Fukui,et al. Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations. , 2003, International journal of pharmaceutics.
[29] Sang-Chul Shin,et al. Enhanced efficacy of triprolidine by transdermal application of the EVA matrix system in rabbits and rats. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[30] D. Attwood,et al. Phase studies on oil-in-water phospholipid microemulsions , 1992 .
[31] N. K. Jain,et al. Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles. , 2008, Nanomedicine : nanotechnology, biology, and medicine.
[32] D. Plumb. Veterinary Drug Handbook , 1999 .
[33] H. Fukui,et al. Evaluation of the efficacy and toxicity of amphotericin B incorporated in lipid nano-sphere (LNS). , 2003, International journal of pharmaceutics.
[34] Amit Kumar,et al. Role of membrane sialic acid and glycophorin protein in thorium induced aggregation and hemolysis of human erythrocytes. , 2010, Biochimie.
[35] M. Glavas-Dodov,et al. The effects of lyophilization on the stability of liposomes containing 5-FU. , 2005, International journal of pharmaceutics.
[36] O. Kayser,et al. Amphotericin B , 2005, Applied Microbiology and Biotechnology.
[37] B. Röder,et al. Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[38] S. Zellmer,et al. Interaction of phosphatidylcholine liposomes with the human stratum corneum. , 1995, Biochimica et biophysica acta.
[39] T. Dutta,et al. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[40] R. Snyderman,et al. Nucleotide regulatory protein-mediated activation of phospholipase C in human polymorphonuclear leukocytes is disrupted by phorbol esters. , 1987, The Journal of biological chemistry.
[41] R. Potts,et al. Lipid thermotropic transitions in human stratum corneum. , 1986, The Journal of investigative dermatology.
[42] H. Fukui,et al. A novel delivery system for amphotericin B with lipid nano-sphere (LNS). , 2003, International journal of pharmaceutics.
[43] A. Hussain,et al. Nanocarrier-based topical drug delivery for an antifungal drug , 2014, Drug development and industrial pharmacy.
[44] M. Rizwan,et al. Nanoemulsion Components Screening and Selection: a Technical Note , 2009, AAPS PharmSciTech.
[45] Liu Wei-na,et al. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. , 2012, International journal of pharmaceutics.